A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Cancer(s): Solid Tumors
Study Phase: phase 1
Status: recruiting
Sponsor: Zai Lab (Shanghai) Co., Ltd. / Zai Lab (US) LLC
ClinicalTrials.gov Identifier: NCT06885281
Disease Focus: Solid Tumors
Principal Investigator: Robert McWilliams, MD, PhD
Clinical Research Coordinator: Peyton Swearingen

Study Overview

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

clinicaltrials.gov NCT:NCT06885281

Interested in Participating in this Trial?

If you are interested in participating in this study, call the OSF Hope line at (844) 673- 4467 or email: sfmc.clinicaltrials@osfhealthcare.org